Z-2746-2026 Class II Ongoing
FDA device recall Z-2746-2026 was initiated by Tosoh Bioscience Inc on Jun 12, 2026 and is designated Class II. Reason for recall: The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low… The recall status is ongoing. Affected quantity: 310 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 22, 2026
- Initiation Date
- Jun 12, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 310 units
Product description
ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204
Reason for recall
The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.
Distribution pattern
Global Distribution. US Nationwide.
Code information
UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2746-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026